Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-141.00
36.00
133.00
177.00
262.00
201.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
249.00
-124.00
-135.00
-62.00
-39.00
-111.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
157.00
-16.00
78.00
192.00
324.00
121.00
Cash Flow from Investing Activities
-17.00
-25.00
-50.00
-112.00
-428.00
-56.00
Cash Flow from Financing Activities
-41.00
-109.00
-131.00
13.00
-121.00
857.00
Net Cash Inflow / Outflow
98.00
-151.00
-103.00
93.00
-226.00
921.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-141.807787113459
434.566795180133
-575.00
-132.63%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
249.854682715241
691.961521214651
-442.00
-63.89%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
157.778963052668
1877.57335151288
-1,720.00
-91.60%
Cash Flow from Investing Activities
-17.6667859329215
-1012.89184872432
995.00
98.26%
Cash Flow from Financing Activities
-41.1100979774539
-1140.54692603368
1,099.00
96.40%
Net Cash Inflow / Outflow
98.4681205678568
-253.044974576106
351.00
138.91%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.53395857443506
22.8204486690208
-22.00
-102.34%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 1,085.23% vs -120.41% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
157.78
-16.01
1,085.23%






